Suppr超能文献

代谢综合征与癌症研究项目(Me-Can)中的总血清胆固醇与癌症发病率。

Total serum cholesterol and cancer incidence in the Metabolic syndrome and Cancer Project (Me-Can).

机构信息

Department of Medical Statistics, Informatics and Health Economics, Innsbruck Medical University, Innsbruck, Austria.

出版信息

PLoS One. 2013;8(1):e54242. doi: 10.1371/journal.pone.0054242. Epub 2013 Jan 23.

Abstract

OBJECTIVE

To investigate the association between total serum cholesterol (TSC) and cancer incidence in the Metabolic syndrome and Cancer project (Me-Can).

METHODS

Me-Can consists of seven cohorts from Norway, Austria, and Sweden including 289,273 male and 288,057 female participants prospectively followed up for cancer incidence (n = 38,978) with a mean follow-up of 11.7 years. Cox regression models with age as the underlying time metric were used to estimate hazard ratios (HR) and their 95% confidence intervals (CI) for quintiles of cholesterol levels and per 1 mmol/l, adjusting for age at first measurement, body mass index (BMI), and smoking status. Estimates were corrected for regression dilution bias. Furthermore, we performed lag time analyses, excluding different times of follow-up, in order to check for reverse causation.

RESULTS

In men, compared with the 1st quintile, TSC concentrations in the 5th quintile were borderline significantly associated with decreasing risk of total cancer (HR = 0.94; 95%CI: 0.88, 1.00). Significant inverse associations were observed for cancers of the liver/intrahepatic bile duct (HR = 0.14; 95%CI: 0.07, 0.29), pancreas cancer (HR = 0.52, 95% CI: 0.33, 0.81), non-melanoma of skin (HR = 0.67; 95%CI: 0.46, 0.95), and cancers of the lymph-/hematopoietic tissue (HR = 0.68, 95%CI: 0.54, 0.87). In women, hazard ratios for the 5th quintile were associated with decreasing risk of total cancer (HR = 0.86, 95%CI: 0.79, 0.93) and for cancers of the gallbladder (HR = 0.23, 95%CI: 0.08, 0.62), breast (HR = 0.70, 95%CI: 0.61, 0.81), melanoma of skin (HR = 0.61, 95%CI: 0.42, 0.88), and cancers of the lymph-/hematopoietic tissue (HR = 0.61, 95%CI: 0.44, 0.83).

CONCLUSION

TSC was negatively associated with risk of cancer overall in females and risk of cancer at several sites in both males and females. In lag time analyses some associations persisted, suggesting that for these cancer sites reverse causation did not apply.

摘要

目的

在代谢综合征与癌症项目(Me-Can)中,研究总血清胆固醇(TSC)与癌症发病率之间的关联。

方法

Me-Can 由来自挪威、奥地利和瑞典的七个队列组成,共包括 289273 名男性和 288057 名女性参与者,前瞻性随访癌症发病率(n=38978),平均随访时间为 11.7 年。使用 Cox 回归模型,以年龄为基础时间指标,估计胆固醇水平五分位数和每 1mmol/l 的风险比(HR)及其 95%置信区间(CI),并调整首次测量时的年龄、体重指数(BMI)和吸烟状况。估计值校正了回归稀释偏差。此外,我们进行了滞后时间分析,排除了不同的随访时间,以检查反向因果关系。

结果

在男性中,与第 1 五分位相比,第 5 五分位的 TSC 浓度与总癌症风险降低呈边缘显著相关(HR=0.94;95%CI:0.88,1.00)。观察到与肝癌/肝内胆管(HR=0.14;95%CI:0.07,0.29)、胰腺癌(HR=0.52,95%CI:0.33,0.81)、非黑素瘤皮肤癌(HR=0.67;95%CI:0.46,0.95)和淋巴/造血组织癌(HR=0.68,95%CI:0.54,0.87)呈显著负相关。在女性中,第 5 五分位的 HR 与总癌症风险降低相关(HR=0.86,95%CI:0.79,0.93)和胆囊癌(HR=0.23,95%CI:0.08,0.62)、乳腺癌(HR=0.70,95%CI:0.61,0.81)、黑色素瘤皮肤癌(HR=0.61,95%CI:0.42,0.88)和淋巴/造血组织癌(HR=0.61,95%CI:0.44,0.83)。

结论

TSC 与女性的总体癌症风险和男性及女性多个部位的癌症风险呈负相关。在滞后时间分析中,一些关联仍然存在,这表明对于这些癌症部位,反向因果关系并不适用。

相似文献

1
Total serum cholesterol and cancer incidence in the Metabolic syndrome and Cancer Project (Me-Can).
PLoS One. 2013;8(1):e54242. doi: 10.1371/journal.pone.0054242. Epub 2013 Jan 23.
3
Body mass index, cholesterol level and risk of lung cancer in Lithuanian men.
Lung Cancer. 2014 Sep;85(3):361-5. doi: 10.1016/j.lungcan.2014.07.009. Epub 2014 Jul 18.
4
Metabolic risk factors and cervical cancer in the metabolic syndrome and cancer project (Me-Can).
Gynecol Oncol. 2012 May;125(2):330-5. doi: 10.1016/j.ygyno.2012.01.052. Epub 2012 Feb 10.
7
Metabolic syndrome and rare gynecological cancers in the metabolic syndrome and cancer project (Me-Can).
Ann Oncol. 2011 Jun;22(6):1339-1345. doi: 10.1093/annonc/mdq597. Epub 2010 Oct 21.
8
Metabolic risk factors and primary liver cancer in a prospective study of 578,700 adults.
Int J Cancer. 2012 Jul 1;131(1):193-200. doi: 10.1002/ijc.26338. Epub 2011 Sep 8.
9
Metabolic risk factors and skin cancer in the Metabolic Syndrome and Cancer Project (Me-Can).
Br J Dermatol. 2012 Jul;167(1):59-67. doi: 10.1111/j.1365-2133.2012.10974.x. Epub 2012 Apr 24.
10
Pooled cohort study on height and risk of cancer and cancer death.
Cancer Causes Control. 2014 Feb;25(2):151-9. doi: 10.1007/s10552-013-0317-7. Epub 2013 Oct 31.

引用本文的文献

1
Risk factors for gastric cancer: an umbrella review of systematic reviews and meta-analyses.
Front Oncol. 2025 Jun 26;15:1564575. doi: 10.3389/fonc.2025.1564575. eCollection 2025.
3
Lipids, apolipoproteins, carbohydrates, and risk of hematological malignancies.
Eur J Epidemiol. 2025 Feb;40(2):187-196. doi: 10.1007/s10654-025-01207-y. Epub 2025 Mar 4.
5
The role of cholesterol metabolism in lung cancer.
Oncol Res. 2024 Sep 18;32(10):1613-1621. doi: 10.32604/or.2024.047933. eCollection 2024.
6
The relationship between lipoproteins and the risk of esophageal cancer: a Mendelian randomization study.
Front Nutr. 2024 Aug 23;11:1432289. doi: 10.3389/fnut.2024.1432289. eCollection 2024.
8
Diabetes and further risk of cancer: a nationwide population-based study.
BMC Med. 2024 May 29;22(1):214. doi: 10.1186/s12916-024-03430-y.
9
Associations between "Cancer Risk", "Inflammation" and "Metabolic Syndrome": A Scoping Review.
Biology (Basel). 2024 May 16;13(5):352. doi: 10.3390/biology13050352.

本文引用的文献

1
Prospective analysis of association between use of statins and melanoma risk in the Women's Health Initiative.
Cancer. 2012 Oct 15;118(20):5124-31. doi: 10.1002/cncr.27497. Epub 2012 Mar 20.
2
Serum total and HDL cholesterol and risk of prostate cancer.
Cancer Causes Control. 2011 Nov;22(11):1545-52. doi: 10.1007/s10552-011-9831-7. Epub 2011 Sep 14.
3
Metabolic risk factors and primary liver cancer in a prospective study of 578,700 adults.
Int J Cancer. 2012 Jul 1;131(1):193-200. doi: 10.1002/ijc.26338. Epub 2011 Sep 8.
4
Total cholesterol and cancer risk in a large prospective study in Korea.
J Clin Oncol. 2011 Apr 20;29(12):1592-8. doi: 10.1200/JCO.2010.31.5200. Epub 2011 Mar 21.
6
Metabolic syndrome and breast cancer in the me-can (metabolic syndrome and cancer) project.
Cancer Epidemiol Biomarkers Prev. 2010 Jul;19(7):1737-45. doi: 10.1158/1055-9965.EPI-10-0230.
8
Apolipoprotein e genotype, plasma cholesterol, and cancer: a Mendelian randomization study.
Am J Epidemiol. 2009 Dec 1;170(11):1415-21. doi: 10.1093/aje/kwp294. Epub 2009 Nov 4.
9
Prediagnostic total and high-density lipoprotein cholesterol and risk of cancer.
Cancer Epidemiol Biomarkers Prev. 2009 Nov;18(11):2814-21. doi: 10.1158/1055-9965.EPI-08-1248. Epub 2009 Nov 3.
10
Association between plasma total cholesterol concentration and incident prostate cancer in the CLUE II cohort.
Cancer Causes Control. 2010 Jan;21(1):61-8. doi: 10.1007/s10552-009-9434-8. Epub 2009 Oct 6.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验